Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy
Not yet recruitingNCT07762703
BreakBio CorpTriple-Negative Breast Cancer (TNBC)
Start: 2026-09-01End: 2030-09-01Target: 10Updated: 2026-08-19